0012| Volume 128, SUPPLEMENT , 154975, March 2022

The use of Rozuvastatin (Rozuvastatin Denk) and Metformin combination in women with abdominal obesity

      Abstract Background. Abdominal obesity is the basic diagnostic criteria for metabolic syndrome. The most important method for preventing metabolic syndrome in its early stages is the effective correction of abdominal obesity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect